The U.S. government continues to end contacts related to the $5 billion Project NextGen initiative, this time terminated ...

Like Johnson & Johnson did during its earnings call the day before, Abbott estimated that global tariffs would end up costing ...

Essa Pharma is facing a call to wind down operations. Soleus Capital Management, one of the company’s largest shareholders, ...

When it came to the study’s secondary endpoints of survival, Telix pointed to a median overall survival (OS) rate of 12.4 ...

For the first quarter of this year, J&J’s total sales of $21.9 billion was up 4.2% over the start of 2024, when accounting ...

Glycomine has bagged a $115 million series C round to continue the progress of its lead candidate through phase 2 development for a rare genetic disorder.